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A B S T R A C T
Macrophage accumulation within the vascular wall is a hallmark of atherosclerosis. Controlling macrophage
conversion into foam cells remains a major challenge for treatment of atherosclerotic diseases. Here, we show
that Wip1, a member of the PP2C family of Ser/Thr protein phosphatases, modulates macrophage migration and
phagocytosis associated with atherosclerotic plaque formation. Wip1 deﬁciency increases migratory and pha-
gocytic activities of the macrophage under stress conditions. Enhanced migration of Wip1-/- macrophages is
mediated by Rac1-GTPase and PI3K/AKT signalling pathways. Elevated phagocytic ability of Wip1-/- macro-
phages is linked to CD36 plasma membrane recruitment that is regulated by AMPK activity. Our study identiﬁes
Wip1 as an intrinsic negative regulator of macrophage chemotaxis. We propose that Wip1-dependent control of
macrophage function may provide avenues for preventing or eliminating plaque formation in atherosclerosis.
1. Introduction
Atherosclerosis is a chronic inﬂammatory disease of the vascular
wall and a leading cause of death and morbidity worldwide.
Macrophage plays an important role in the development of athero-
sclerosis [10,20,5]. An early event in atherogenesis is the adherence of
monocytes to endothelial cells [17]. After transmigrating across the
endothelia layer, these monocytes mature into macrophages that pha-
gocytose lipids to become macrophage foam cells, leading to the pro-
gressive development of atherosclerotic plaques [14]. Suppression of
macrophage conversion into foam cells can prevent the formation of
atherosclerotic plaques. However, the knowledge gap in understanding
the mechanisms that underlie the control of macrophage function in
atherogenesis has been a setback in the development of novel therapies
for this disease.
The wild-type p53-induced phosphatase 1 (Wip1) is a member of
the PP2C family of Ser/Thr protein phosphatases that play important
roles in cellular stress responses. While Wip1 was originally discovered
as an oncogene by virtue of its negative control on several key tumor
suppressor pathways [4,7], emerging evidence has linked Wip1 func-
tion in multiple cellular processes [15,27,29]. A recent study by Gue-
zennec et al. showed the involvement of Wip1 in control of athero-
sclerosis [13]. Speciﬁcally, genetic ablation of Wip1 resulted in
suppression of macrophage conversion into foam cells by means of the
ATM/mTOR signalling pathway that regulates autophagic clearance of
lipid droplets in the plagues.
Many studies have established that atherosclerotic plaque regression
was associated with the disappearance of foam cells caused by their emi-
gration from plaques into regional lymph nodes [16,23]. Interventions that
directly encourage macrophage departure from plaques might synergize
with cholesterol-lowering therapies to more eﬀectively treat atherosclerotic
diseases [9]. In the present study, we show that Wip1 negatively regulates
macrophage migration and phagocytosis during the development of ather-
osclerotic plaques. Macrophages lacking the expression of Wip1 displayed
enhanced migration that is associated with activation of Rac1-GTPase and
PI3K/AKT pathways. The enhanced phagocytic ability of Wip1-/- macro-
phages was regulated by AMPK activity. These ﬁndings provide a new
therapeutic target for prevention or treatment of plaques in atherosclerosis.
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2. Results
2.1. Wip1 negatively regulates macrophage migration and pseudopodia
formation
We used J774A.1, a murine macrophage cell line [18], to examine
the biological function of Wip1 in modulation of cell migration. Lipo-
fection mediated transfection of pcDNA3.1 (Wip1) into J774A.1 cells
led to 1.6 fold increase of Wip1 protein expression. J774A.1 cells with
shRNA knockdown of Wip1 expression displayed high migratory rates
compared with those transfected with a non-speciﬁc shRNA (as con-
trol). See the Supplementary Fig. 1. When Wip1 was overexpressed in
J774A.1 cells, the migratory rate decreased signiﬁcantly (Fig. 1A).
Results from multiple experiments were summarized in Fig. 1B, and
showed that macrophage migration rate negatively correlated with
Wip1 protein expression.
We next used primary cells to further examine the biological func-
tion of Wip1 in modulation of cell migration. Primary peritoneal mac-
rophages were isolated from the Wip1-/- and WT littermates and cul-
tured by an adherence screening method [22] (Fig. 1C). Genotyping of
the Wip1-/- mice is shown in Supplementary Fig. 2. Cell sorting using
macrophage markers of CD11b and F4/80 enhanced the selection of the
macrophages population in our experiments (Supplementary Fig. 3).
After serum-depletion for 3 h, we found that actin in the WT macro-
phages displayed random orientations with no appreciable formation of
pseudopodia. In contrast, many Wip1-/- macrophages appeared “polar-
ized” and tended to form pseudopodia (Fig. 1G). We used a transwell
migration assay to determine whether the pseudopodia structure is
linked to altered migration of macrophages. Fig. 1F showed that there
was no diﬀerence in the adhesion of macrophages between the Wip1-/-
group and WT group, as the OD values were comparable at 1 h and 3 h
under normal culture conditions. However, the migratory ability of the
Wip1-/- group was signiﬁcantly greater than the WT group (Fig. 1D).
Compared with the WT group, the Wip1-/- cells displayed 76% more
migratory activity (p<0.01) (Fig. 1E). These data suggest that genetic
ablation of Wip1 led to enhanced migratory property of the macro-
phages.
2.2. Knockout of Wip1 promotes macrophage migration away from
inﬂammation
For in vivo assessment of macrophage migration, we used ﬂuores-
cence labelling of primary cultured macrophages derived from the WT
or Wip1-/- mice. WT macrophages stained positive for Light yellow
(green) or Wip1-/- macrophages stained positive for Nile red (red) were
identiﬁed with APC labelled F4/80 using FACS analysis. Equal amounts
of the WT and Wip1-/- macrophages (6×104 cells each) were co-in-
jected into the WT mice with on-going inﬂammation triggered by
thioglycollate injection 24 h before (Fig. 2A). Three hours after injec-
tion, ﬂow cytometry detected 1.3% of Light yellow labelled WT mac-
rophages in the peritoneal cavity, whereas only 0.3% of Nile red-la-
belled Wip1-/- macrophages were identiﬁed under identical conditions
(Fig. 2B). Similar observation was observed in two other separate ex-
periments. Thus, Wip1-/- macrophages showed increased emigration
from the peritoneal cavity.
Further study revealed that Wip1-/- promoted macrophage migra-
tion away from inﬂammation in vitro. As shown in Fig. 2C, when
lipopolysaccharide (LPS) was added into the upper well of the transwell
assay system, the Wip1-/- macrophages showed greater migratory ac-
tivity than the WT macrophages. Conversely, when LPS was added into
the lower well, the promoting eﬀect of the Wip1 deletion on the mi-
gration of macrophages was diminished; and the migratory activity of
both WT and Wip1-/- cells was reduced to similar levels. The results
were normalized to the number of WT control cells that migrated
(Fig. 2D).
Previous studies by other investigators demonstrated that PI3K/AKT
signalling was involved in cell migration [25]. To ascertain the con-
tribution of this pathway in the Wip1-/- induced migration of macro-
phages, we dephosphorylated AKT prior to performing a transwell
migration assays. We found that addition of a PI3K/AKT inhibitor,
LY294002, signiﬁcantly impaired WT and Wip1-/- macrophage migra-
tion (Fig. 2E). Statistical analyses showed that the addition of
LY294002 abolished the diﬀerence in migration property of the WT and
Wip1-/- cells (Fig. 2F). A role of AKT phosphorylation in regulating
mobility of Wip1-/- macrophages was further assessed by western blot
analysis. As shown in Fig. 2G and H, 3 h after incubation of Wip1-/-
macrophages in serum-free media, there was signiﬁcant increase the
relative expression in phosphorylation of AKT at Ser473 over the WT
macrophages (p<0.01). This data conﬁrmed that AKT signalling was
involved in the migratory potential of macrophages.
2.3. Increased migration in Wip1-/- macrophage is attributable to enhanced
Rac1-GTPase
Rho GTPases such as Rac, RhoA and CDC42 play crucial roles in cell
migration [11]. While Wip1 deﬁciency did not appear to aﬀect the
mRNA and protein expressions of Rac1, RhoA, and CDC42 (Fig. 3A and
B), Wip1-/- macrophages displayed signiﬁcant increase in Rac1-GTPase
activity (p< 0.01) over the WT cells, whereas the activity of RhoA and
CDC42 remain unchanged (Fig. 3C). Incubation of cells with
NSC23766, a known inhibitor of Rac1-GTPase [8], reduced the GTPase
activity in both WT and Wip1-/- macrophages and impaired the mi-
gratory activity of both cell groups as measured in the transwell mi-
gration assay (Fig. 3D, E). Moreover, in the presence of NSC23766, WT
andWip1-/- cells displayed similar migration properties, suggesting that
the altered Rac1-GTPase activity is a main contributing factor for the
Wip1-dependent macrophage migration.
To dissect the functional relationship between PI3K/AKT and Rac1
in Wip1-mediated macrophage migration, we performed experiments
with WT and Wip1-/- cells using the PI3K/AKT inhibitor. As shown in
Fig. 3F, incubation with NSC23766 blocked phosphorylation of AKT in
both WT andWip1-/- macrophages. Interestingly, the activation of Rac1
in response to C5a treatment was not suppressed by LY294002, instead
was increased by 55% (p<0.01) in WT macrophages (Fig. 3G). How-
ever, LY294002 has no obvious eﬀect on Rac1 activation in Wip1-/-
macrophages. According to these data, we speculate that Wip1 likely
participate in the intermediate signalling steps between Rac1 and PI3K/
AKT.
2.4. Wip1-/- promotes CD36 plasma membrane recruitment via activation
of AMPK pathway
FACS analysis of macrophages for migration studies showed that
greater numbers of Wip1-/- macrophages were identiﬁed to have larger
Fig. 1. Wip1 modulates macrophage migration. (A) Overexpression of Wip1 inhibited macrophage migration through transwell ﬁlters, whereas knockdown of Wip1 promoted migration.
The migratory capacity was tested by stimulation with 10 nmol/L C5a for 3 h. Scale bars, 100 µm. (B) The results were normalized to the number of control macrophages that migrated,
and are presented as the means± SEM of 5 independent experiments performed in triplicate. *: p< 0.05, **: p< 0.01. (C) Morphology of macrophages extracted from the abdominal
cavity of WT and Wip1-/- mice after 3 h adherence. Scale bars, 100 µm. (D) Knocking out Wip1 promoted macrophage migration through transwell ﬁlters, and the migratory capacity was
tested by stimulation with 10 nmol/L C5a for 3 h. Scale bars, 100 µm. (E) The results were normalized to the number of control macrophages that migrated and are presented as the
means± SEM of 5 independent experiments performed in triplicate. **: p< 0.01. (F) Anchorage-dependent rate and CCK8 colourimetry measurement show that Wip1 ablation does not
aﬀect cell attachment. (G) Fluorescence confocal microscopic images of F-actin in macrophages via rhodamine-phalloidin staining. Arrows represent images of the pseudopodia structure
in Wip1-/- macrophages. Scale bars, 20 µm.
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forward scatter area compared with WT macrophages. This data sug-
gests the possibility thatWip1-/- might enhance the phagocytotic ability
of macrophages. Accordingly, we determined whether Wip1 aﬀected
the expression of speciﬁc surface molecules (CD36, CD64, CD204 and
CD284) associated with phagocytosis. As shown in Fig. 4A, FACS ana-
lysis revealed thatWip1-/- promoted CD36 recruitment to macrophages.
There were no signiﬁcant diﬀerences in the other surface molecules
(e.g. CD64, CD204 and CD284) between the WT and Wip1-/- cells. We
next used western blot to assess the expression of CD36 in the cyto-
membrane of macrophages. As shown in Fig. 4B, following 3 h of in-
cubation with ﬂuorescently labelled beads and LPS (10 mg/L), Wip1-/-
macrophages exhibited signiﬁcantly higher level of CD36 recruitment
than that of the WT macrophages. The elevated level of CD36 recruit-
ment was sustained at 6 h of incubation (p< 0.05) (Fig. 4C).
Studies from other investigators have established a role for AMPK in
regulation of phagocytosis [3]. We analysed the relationship between
CD36 and AMPK pathways in macrophages using the AMPK speciﬁc
inhibitor - compound C, and AMPK activator-AICAR. As shown in
Fig. 4D and E, western blot revealed that the basal level of AMPK
phosphorylation was elevated in Wip1-/- macrophages compared with
that in WT macrophages (p<0.01). Pre-treatment with Compound C
signiﬁcantly inhibited AMPK phosphorylation in Wip1-/- macrophages
(p<0.01), and with negligible eﬀects on WT macrophages (p> 0.05).
This correlates with signiﬁcant reduction of CD36 recruitment in
Wip1-/- cells (Fig. 4D). On the other hand, pre-treatment of cells with
AICAR enhanced AMPK activation to a greater extent in WT macro-
phages (4.0± 0.5 fold) than that in Wip1-/- macrophages (1.7± 0.3
fold). This translates into a signiﬁcant increase in CD36 levels in WT
cells with treatment of AICAR, whereas a minimum increase in CD36
was observed in Wip1-/- cells following treatment with AICAR.
To further quantify the eﬀects of Wip1 on macrophage phagocy-
tosis, we used confocal microscopy. As shown in Fig. 5A, Wip1-/-
macrophages displayed increased capacity to ingest ﬂuorescently la-
belled beads compared with the WT macrophages. Statistical analysis of
the confocal microscopic data showed that treatment with AICAR in-
creased the number of labelled macrophages to similar levels in WT and
Wip1-/- cells. Treatment of cells with Compound C reduced the number
of labelled macrophages to similar levels in WT and Wip1-/- cells
(Fig. 5B). Consistent with previous report by other investigators [1,8],
we found that AMPK activation enhanced the intensity of actin staining
in macrophages, predominantly in proximity to the membrane edges
and the zone of ﬁlopodia, and such process could be reversed by AMPK
inhibitor Compound C. Overall, our data demonstrated that the en-
hanced phagocytotic activity of Wip1-/- macrophages was mediated by
CD36 membrane recruitment and regulated by AMPK activity.
3. Discussion
Atherosclerosis is a chronic inﬂammatory disease of the vascular
wall, and has become a leading cause of death and morbidity world-
wide. Macrophage is a key regulator of plague formation in athero-
sclerosis [19,30]. Using the Wip1-/- mouse model, we provide evidence
that Wip1 negatively modulates macrophage migration and phagocy-
tosis that is associated with the development of atherosclerotic plaques.
Previous studies showed that selective disposal of plaques represents an
eﬃcient means for treating atherosclerosis [12]. Here we show that
Wip1 deﬁciency enhanced pseudopodia formation and migration of
macrophages under stress conditions. Our in vivo studies showed that
Wip1-/- macrophages displayed increased emigration from the perito-
neal cavity. Moreover, enhanced phagocytotic activity was another
signature of the Wip1-/- macrophage. Based on these data, we conclude
that Wip1 functions as a negative regulator of macrophage chemotaxis.
We propose that Wip1-dependent control of macrophage function may
provide avenues for preventing or eliminating plaque formation in
Fig. 2. Wip1 deﬁciency promotes macrophage migration away from inﬂammation via PI3K/AKT pathways. (A) Equal number of Nile Red labelled Wip-/- and Light Yellow labelled WT
macrophages were injected into the peritoneal cavity of thioglycollate-stimulated WT mice. The amount of labelled macrophages in the cavity was analysed by FACS 3 h after the
injection. (B) Flow cytometry showed more Light Yellow labelled WT macrophages remained in the peritoneum compared to Nile Red labelled Wip1-/- macrophages. Data are re-
presentative of three independent experiments. (C) The migratory capacity was tested by stimulation with 10 nmol/L C5a for 3 h. LPS was added (10 mg/L) in the upper or/and lower
chamber for 3 h. Migrated macrophages were quantiﬁed after ﬁxation and DAPI staining. Scale bars, 100 µm. (D) The results were normalized to the number of WT macrophages that
migrated and are presented as the means± SEM of 5 independent experiments performed in triplicate. ***: p< 0.001. (E) Macrophages from WT or Wip1-/- mice were seeded on
transwell ﬁlters, and their migratory capacity was evaluated via stimulation in the presence of a PI3K/AKT inhibitor (LY294002, 50 µM) for 3 h. Migrated macrophages were quantiﬁed
after ﬁxation and DAPI staining. Scale bars, 100 µm. (F) The results were normalized to the number of WT macrophages that migrated and are presented as the means± SEM of 5
independent experiments performed in triplicate. **: p< 0.01. (G) Western blot analysis of mouse macrophages. The cells were incubated in media lacking serum for 3 h. TheWip1-/-cells
displayed higher expression of pAKT than the WT cells. (H) Determination of the pAKT/AKT ratio after 3 h of incubation via grey-scale image analysis. The results are presented as the
means± SEM of 3 independent experiments performed in duplicate.**: p< 0.01.
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Fig. 3. Increased migration of Wip1-/- macrophage is attributed to enhanced Rac1-GTPase. (A-B) Western blot and real time PCR analysis demonstrated that Wip1 did not aﬀect the expression
of Rho family member (Rac1, RhoA, CDC42) mRNA and protein levels. (C) Knocking outWip1 increased the activity of Rac1-GTPase, but not RhoA and CDC42-GTPase. After the adherent
macrophages were serum-depleted for 3 h, Rac1, RhoA and CDC42-GTPase activity were analysed using cell lysates and commercially available ELISA kits. The results are presented as
the means± SEM of 6 independent experiments performed in triplicate. **: p< 0.01. (D) Macrophages from WT or Wip1-/- mice were seeded on transwell ﬁlters (5 µm), and their
migratory capacity was evaluated via stimulation in the presence of a Rac1 inhibitor (NSC23766, 100 µM) for 3 h. Migrated macrophages were quantiﬁed after ﬁxation and DAPI staining.
Scale bars, 100 µm. (E) The results were normalized to the number of WT macrophages that migrated, which are presented as the means± SEM of 5 independent experiments performed
in triplicate. **: p< 0.01. (F) Western blot analysis demonstrated that phosphorylation of AKT was inhibited by Rac1 inhibitor (NSC23766, 100 µM) both in the WT and Wip1-/-
macrophages. (G) The results are presented as the means± SEM of 3 independent experiments performed in duplicate.
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atherosclerosis.
During migration, the cells undergo polarization with extension of
pseudopodia at the leading edge [26], a coordinated cellular process
involving the Rho family GTPases [28]. We found that Wip1 deﬁciency
increased level in the active form of Rac1 GTPase and promoted the
migration of macrophages. Active Rac1 at the leading edge of pseu-
dopodia was reported to mediate actin polymerization and produce
ﬁlamentous extensions and forward cell movement [21,24]. Under
serum-free selection pressure,Wip1-/- macrophages displayed enhanced
chemotaxis. Previous research suggested that PIP3 accumulates at the
cell front in a feedback loop involving PI3K and Rac1-GTPase during
chemotaxis [33]. In addition, PI3K/AKT signalling pathways are also
involved in cell migration [25,32], and PI3K/AKT was reported to act
both upstream and downstream of Rho-GTPases [2]. Our data suggest
that the migratory ability of WT and Wip1-/-macrophages was blocked
by the PI3K/AKT inhibitor LY294002.
Rac1-regulated signalling can be mediated by a variety of down-
stream eﬀectors [31]. By inhibiting Rac1, the phosphorylation of AKT
was signiﬁcantly inhibited in both WT and Wip1-/- macrophages. This
ﬁnding indicated that Rac1 is an upstream regulatory factor of the
PI3K/AKT pathway. Furthermore, results reveal that Wip1 might act as
a downstream eﬀector of PI3K/AKT in peritoneal macrophages. Thus,
Fig. 4. Knocking out Wip1 in macrophages promotes CD36 cytomembrane recruitment. (A) Expression of CD36, CD64, CD204, CD284 in WT and Wip1-/- macrophage cytomembrane were
analysed via ﬂow cytometry. Data are representative of three independent experiments. (B) Western blot showed the expression of CD36 in WT and Wip1-/- macrophage cytomembrane.
Cytomembrane recruitment of CD36 was signiﬁcantly greater in Wip1-/- macrophages compared to WT after incubation with ﬂuorescently labelled beads and LPS (100 ng/mL). (C)
Determination of the CD36 relative expression ratios were shown by grey-scale image analysis. The results are presented as the means± SEM of 3 independent experiments performed in
duplicate. *: p<0.05. (D) Western blot demonstrated that the expression of CD36 and pAMPK were inhibited by an AMPK pathway inhibitor (Compound C, 10 µM) and stimulated by an
AMPK pathway activator AICAR (1 mM) in WT andWip1-/- macrophages. (E) Determination of the ratio of CD36 and pAMPK relative expressions by grey-scale image analysis. The results
are presented as the means± SEM of 3 independent experiments performed in duplicate. *: p< 0.05, **: p< 0.01.
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Wip1 may provide distal feedback to regulate the activation of Rac1
and the phosphorylation of AKT. Up-regulation of pAKT might be in-
directly increased or stabilized by Wip1 expression.
Deletion of Wip1 results in the suppression of macrophage conver-
sion into foam cells. This process appears to be independent of p53, but
relies on a noncanonical ATM-mTOR signalling pathway for selective
autophagy in the regulation of cholesterol eﬄux, thus preventing the
formation of atherosclerotic plaques [13,15]. In Wip1-/- macrophages,
Anna et al. also observed that mTOR kinase is down regulated through
the activation of AMPK, and knocking-down TSC2 reversed the in-
hibitory eﬀect of Wip1 deﬁciency on foam cell formation [3]. AMPK
activation increased the ability of neutrophils or macrophages to ingest
bacteria, as well as the ability of macrophages to ingest apoptotic cells
[1]. Our studies indicate that Wip1 deﬁciency-mediated activation of
AMPK increase the phagocytosis of ﬂuorescent particles. The Wip1-/-
macrophages displayed a signiﬁcant increase of CD36 recruitment to
Fig. 5. Knocking out Wip1 in macrophages promotes phagocytosis through the AMPK pathway. (A) WT and Wip1-/- peritoneal macrophages were cultured with or without compound C
(10 µM) or AICAR (1 mM). Representative ﬂuorescence confocal microscopic images show that activation of AMPK increased, whereas compound C diminished, the uptake of ﬂuorescent
labelled beads by the WT and Wip1-/- macrophages. Green, Alex Flour-488 phalloidin; red, Nile Red ﬂuorescent labelled particles; blue, nuclei. Scale bars, 50 µm. (B) The results were
normalized to the number of control WT macrophage that phagocytosed particles, which are presented as the means± SEM of 3 independent experiments performed in triplicate.*:
p<0.05, **: p< 0.01.
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their cytomembranes. Through the use of AMPK activators and in-
hibitors, we demonstrate that Wip1 regulates CD36 recruitment in
macrophages through the AMPK pathway.
In summary, our study supports the concept that Wip1 acts as a
negative regulator of macrophage migration and phagocytosis through
the Rac1-GTPase, PI3K/AKT and AMPK pathways. We propose that
inhibiting the expression of Wip1 could prevent the formation of pla-
ques, and might provide a new therapeutic target for treatment of
atherosclerosis.
4. Materials and Methods
4.1. Materials
Rac1-GTP, RhoA-GTP and CDC42-GTP colorimetric ELISA kits were
purchased from Cytoskeleton, Inc. FITC-CD11b and APC-F4/80 were
purchased from MACS. Immunoblotting was performed using the fol-
lowing antibodies: Wip1 (D4F7), AKT, p-AKT (Ser473), p-AKT
(Thr308), AMP-dependent protein kinase (AMPK), p-AMPK (Thr172),
CD36 and GAPDH (14C10) (Cell Signalling Technology). Five-micron
polycarbonate ﬁlters and 6-well culture plates were purchased from
Costar. DAPI was obtained from Sigma. The rhodamine-phalloidin and
Alexa Fluor® 488-phalloidin stains were purchased from Life
Technologies. A Cell Counting Kit-8 (CCK8) was obtained from Dojindo
Molecular Technology Corporation (Japan). Fluorescent Light Yellow
and Nile Red particles (0.7–0.9 µm) were purchased from Spherotech.
Bacterial LPS (LPS; Escherichia coli 055:B5) was purchased from Sigma-
Aldrich.
4.2. Mice
Wip1-/- mice were kindly provided by the Key Laboratory of Human
Diseases Comparative Medicine of the Ministry of Public Health
(Peking, China) [6]. All mice were bred and maintained under pa-
thogen-free conditions. Sex-matched littermate wild type (WT) mice at
8–10 weeks of age were used for the experiments, unless otherwise
noted. The animal protocols were approved by the Animal Ethics
Committee of the Institute of Animal Sciences in Peking, China.
4.3. Cell culture and treatment
Peritoneal macrophage cells were harvested from WT and
Wip1-/- mice 24 h after receiving an intraperitoneal injection of 1 mL
3% thioglycollate. After injection of 5 mL of tissue culture medium
(DMEM media, Life Technologies, USA) into the abdominal cavity,
peritoneal cells were harvested. These cells were then distributed on 6-
well culture plates, at a density of 2×106 cells/plate with DMEM media
containing 10% fetal bovine serum (FBS), and incubated at 37 °C, in an
atmosphere of 5% CO2 for 2 h. Macrophages that adhered onto plates
were used for further study. The murine macrophage cell line J774A.1
was purchased from Chinese Peking Union Medical College. The cells
were cultured in DMEM with 10% FBS, penicillin (100 U/mL), strep-
tomycin (100 µg/mL), and 4 mM glutamine at 37 °C.
4.4. CCK8 assay of cell adhesion
Macrophages (WT and Wip1-/-) were seeded at 1×105 cells/well in 96-
well plates with 10% serum conditions for 1 and 3 h. After 1 or 3 h, non-
adherent cells were removed by washing with culture medium. Then, the
number of adherent cells was measured using a CCK8 assay kit according to
the manufacturer's protocol. For each well, macrophages were mixed with
10 µl of CCK-8 solution and incubated for 2 h at 37 °C. The amount of
formazan dye generated by the activity of cellular dehydrogenases was
measured at 450 nm using a microplate reader. Optical density (OD) values
of each well represented the number of adherent cells. All experiments were
performed in ﬁve replicates.
4.5. Transwell migration assay
Macrophages were seeded at a density of 1×105 cells on top of 5-
µm polycarbonate ﬁlter inserts in transwell chamber plates (Costar).
Migration capacity was determined by placing ﬁlter inserts containing
the cells into wells containing 600 µl of DMEM supplemented with 10%
FBS, 10% Glutamax I (Gibco) and 10 nmol/L C5a. Migration was al-
lowed to proceed for 3 h at 37 °C in a 5% CO2 incubator. After in-
cubation, the ﬁlters were ﬁxed with 4% paraformaldehyde, and cells
that had not migrated were removed from the upper surface of the ﬁlter
by scraping using premium quality soft cotton buds. Filters were then
stained with 1 µl/mL Hoechst (Beyotime), washed with PBS, and sub-
sequently observed under a ﬂuorescence microscope (Nikon). Filters
were visualized using a 20× objective, and the number of cells that had
migrated across ﬁlters was counted at the bottom of each ﬁlter in at
least 9 random ﬁelds.
4.6. In vivo migration
For in vivo migration experiments, ﬂuorescence labelled beads
(Light yellow or Nile red) (250 µl of 40 µl beads in 1 mL sterile phos-
phate buﬀer saline) were injected into the peritoneal cavity of 24-h
post-thioglycollate stimulated mice (WT or Wip1-/-). Three hours later,
cells were isolated from the peritoneal cavity and stained for the
macrophage marker F4/80. Using FACS, macrophages staining posi-
tively for Light yellow (green) or Nile red (red) were identiﬁed with
APC labelled F4/80 and sorted (BD FACSAria Cell Sorter).
Subsequently, equal amounts of cells positive for beads and F4/80 la-
belled macrophages were re-injected into mice with ongoing in-
ﬂammation triggered by thioglycollate injection 24 h before. Three
hours later, remaining numbers of labelled macrophages were de-
termined by FACS as a percentage of total macrophages.
4.7. F-actin staining
Macrophages were cultured on coverslips for 24 h, incubated in
media lacking FBS for 3 h or 6 h, and then ﬁxed with 4% paraf-
ormaldehyde in the presence of 1 U/mL rhodamine-phalloidin for
30 min at room temperature. Then, coverslips were mounted on slides
and observed using an Axioskop 3-channel confocal microscope
(Zeiss710). Images were obtained via z-scanning and were analysed
using Zen2010 software. At least three separate ﬁelds from triplicate
wells were analysed per experiment for each genotype.
4.8. Assay of Rac1-GTPase activity
Macrophages were cultured in 6-well plates for 48 h in growth
media, followed by incubation in DMEM (lacking FBS) for another 6 h.
Then, the cells were lysed in lysis buﬀer, and the Rac1-GTP, RhoA-GTP
and CDC42-GTP levels were measured according to the manufacturer's
instructions (Cytoskeleton, Inc.).
4.9. In vitro phagocytosis assay
Phagocytosis of ﬂuorescently labelled beads was determined by
adding a 10-fold excess of ﬂuorescent beads (0.7–0.9 µm diameter size)
to a cell climbing piece. To measure the internalization of beads, they
were incubated with macrophages for 3 h at 37 °C, and cells were then
washed 3 times within ice-cold PBS. After ﬁxing in 4% paraformalde-
hyde for 30 min and permeabilizing using 0.5% Triton X-100 for
10 min, the cells were incubated in Alexa Fluor 488-phalloidin (Green)
for 30 min at room temperature. DAPI counterstaining was performed
for 20 min to visualize the DNA. Fluorescence was detected using an
Axioskop 3-channel confocal microscope (Zeiss710), and the ﬂuores-
cence intensity was quantiﬁed using Image J software. Amounts of
ﬂuorescent beads/cell were calculated using IP-lab software. At least
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three separate ﬁelds from triplicate wells were analysed per experiment
for each genotype.
4.10. Statistical analysis
All data are presented as the means± standard deviation (SD).
Statistical signiﬁcance was determined using the Bonferroni post-hoc
test and/or Student's t-test; p< 0.01 was considered to be statistically
signiﬁcant.
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